Trials / Completed
CompletedNCT01921907
Evaluation of a Topical Treatment for Actinic Keratosis
Phase 2 Double-blind, Randomized, Placebo-controlled, Parallel Group, Multi-center Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Assuta Hospital Systems · Academic / Other
- Sex
- All
- Age
- 30 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
A topical treatment applied twice daily for 4 weeks to induce disappearance of facial actinic keratosis (AK). First 4 weeks treatment (visit 1, 2 and 3 at 0,2 an 4 weeks) treated as a double blind parallel study. From weeks 4 to 7 (visit 3 to visit 4) all patients to be treated by the active component.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD17137 topical treatment | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-06-01
- Completion
- 2014-07-01
- First posted
- 2013-08-14
- Last updated
- 2015-03-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01921907. Inclusion in this directory is not an endorsement.